arrow
Back
S

Silke Gillessen

Ente Ospedaliero Cantonale

79H-index
545Paper Count
3.3WCitation Count
Published Papers 220
Publication Date
Imaging and Clinical Correlates of [177Lu]Lu-PSMA PET-Defined Eligibility in De Novo Metastatic Prostate Cancer
err2026-08-13
err0
errOAAI
errGiovanna Pecoraro; Marco Cuzzocrea; Cesare Michele Iacovitti; Marialuisa Puglisi; Chiara Martinello; Alberto De Giorgi; Sara Merler; Luigi Tortola; Hui-Ming Lin; Gianmarco Leone; Fabio Turco; Ricardo Pereira Mestre; Giorgio Treglia; Ursula Vogl; Silke Gillessen; Martino Pedrani; Gaetano Paone
errShare
errSave
EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate Cancer
err2026-08-05
err0
PREAI
errGuillaume Grisay; Fabio Turco; Anna Patrikidou; Enrique Gallardo; Ray McDermott; Erik Briers; Beatrice Fournier; Olga Basova; Bert Dhont; Marcell Csanádi; Silke Gillessen; Bertrand Tombal
errShare
errSave
DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives
errDrugs
IF14.4
err2026-07-29
err0
PREAI
errGiovanna Pecoraro; Alberto De Giorgi; Giulia Montelatici; Giuseppe Salfi; Hui-Ming Lin; Fabio Turco; Tarek Taha; Himisha Beltran; Johann de Bono; Rahul Raj Aggarwal; Gunhild von Amsberg; Markus Joerger; Martina Imbimbo; Ilaria Colombo; Silke Gillessen; Martino Pedrani
errShare
errSave
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression
err2026-05-29
err0
PREAI
errFabio Turco; Silke Gillessen; Giuseppe Salfi; Iris S. H. Kloots; Peter H. J. Slootbeek; Niven Mehra; Matthew Labriola; Daniel J. George; Amanda Broderick; Anna Patrikidou; Hortense Patry; Consuelo Buttigliero; Veronica Crespi; Hirotsugu Uemura; Kazutoshi Fujita; Takanobu Utsumi; Hiroyoshi Suzuki; Daniele Raggi; Umberto Basso; Rafael Morales-Barrera; David Marmolejo Castaneda; Cora N. Sternberg; Daniela Guevara; Orazio Caffo; Giuseppe Procopio; Andrea Zivi; Sara Merler; Mariella Sorarù; Daniel E. Spratt; Pedro C. Barata; Carlo Messina; Yüksel ürün; Hatice Bolek; Ignacio Duràn; Juan Diego Cacho Lavin; Nieves Martínez Chanzá; Lisa G. Horvath; Rhiannon Mellor; Levent Türkeri; Merve Bengisu Soykök; Sabrina Rossetti; Richard Cathomas; Giuseppe Luigi Banna; Vincenza Conteduca; Margaret Ottaviano; Laura Marandino; Hui-Ming Lin; Luigi Tortola; Ricardo Pereira Mestre; Martino Pedrani
errShare
errSave
Hot flushes during ADT for prostate cancer — a clinical rationale for a neurokinin 3 receptor antagonist
err2026-04-28
err0
PREAI
errMartino Pedrani; Bertrand Tombal; Pierre Blanchard; Silke Gillessen
errShare
errSave
Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC–ESTRO OligoCare consortium
err2026-04-27
err0
PREAI
errJoachim Widder; Guus M Bol; Inga-Malin Simek; Felix Ehret; Hoda Abdel-Aty; Selma Basic; David Chuter; Jacqueline Daly; Patricia Fairbrother; Donjeta Zeqa; Frank Aboubakar Nana; Verane Achard; Stefanie Corradini; Dora Correia; Dirk De Ruysscher; Anne-Marie C Dingemans; Corinne Faivre-Finn; Silke Gillessen; Marianne G Guren; Lizza Hendriks
errShare
errSave
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14)
err2026-03-19
err0
errOAAI
errS. Gillessen; K. Gobat; R. Cathomas; N. Fischer; R. Pereira Mestre; T. Hermanns; S.I. Rothschild; N. Mach; W. Mingrone; M. Ciriolo; B. Müller; A. Erdmann; C. Schär; C. Mamot; P. Bohanes; A. Omlin; S. Bastian; K. Ribi; L. Mazzucchelli; J. Barizzi
errShare
errSave
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations
errCancers
IF4.4
err2026-03-03
err0
errOAAI
errGiuseppe Salfi; Martino Pedrani; Amos Colombo; Lorenzo Ruinelli; Daniele Brenna; Chiara Maria Agrippina Clerici; Giovanna Pecoraro; Sara Merler; Caroline-Claudia Erhart; Marialuisa Puglisi; Fabio Turco; Luigi Tortola; Ursula Vogl; Silke Gillessen; Ricardo Pereira Mestre
errShare
errSave
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.
err2026-02-26
err0
errOAAI
errS. Gillessen; E. Gallardo; A. Choudhury; F. Saad; A. Soares; Y. Loriot; R. McDermott; A. Rodriguez-Vida; P. Isaacsson Velho; F. Nolè; F. Cruz; T. Roumeguere; G. Daugaard; R. Yamamura; E. Bompas; P. Maroto; F.Gomez Veiga; I. Skoneczna; K. Martins da Trindade; F. Mavignier Carcano
errShare
errSave
Drug re-purposing to improve outcomes in the management of prostate cancer – aims, outcome measures and design of current phase III trials
err2026-01-24
err0
errOAAI
errDuncan C. Gilbert; Ruth E. Langley; Dami Ayadi; Mannab Berhanu; Lakshmi Kowdley Hemanth; Seunghee Kwon; Hossameldin Abdallah; Angela Meade; Noel Clarke; Silke Gillessen; Nicholas James; Gauthier Bouche; Mahesh Parmar; Matthew Nankivell; Laura Murphy
errShare
errSave
Letter to the Editor: Capivasertib plus abiraterone in PTEN-deficient metastatic hormone sensitive prostate cancer: CAPItello-281 phase III study
err2025-12-15
err0
PREAI
errFabio Turco; Ursula Maria Vogl; Hui Ming Lin; Martino Pedrani; Gianmarco Leone; Silke Gillessen
errShare
errSave
Beyond Menopause: Ending the Inequality—Why Men with Prostate Cancer Still Lack Therapies for Hot Flushes
err2025-12-13
err0
PREAI
errMartino Pedrani; Silke Gillessen; Erik Briers; Pierre Blanchard; Anthony M. Joshua; Bertrand Tombal
errShare
errSave
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
err2025-11-21
err0
PREAI
errUrsula M. Vogl; Sara Merler; Antonio Angrisani; Fabio Turco; Ian D. Davis; Jason A. Efstathiou; Karim Fizazi; Nicholas D. James; Neal Shore; Eric J. Small; Matthew R. Smith; Christopher J. Sweeney; Bertrand Tombal; Thomas Zilli; Ken Herrmann; Aurelius Omlin; Silke Gillessen
errShare
errSave
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced prostate cancer
err2025-11-05
err0
errOAAI
errSungmin Woo; Luca Russo; Samuel J. Withey; Ailin Dehghanpour; Roberto García-Figueiras; Ivo G. Schoots; Giuseppe Petralia; Amish Lakhani; Tobias Penzkofer; Martina Pecoraro; Chen-Jiang Wu; Jochen Walz; Matthias Eiber; Wolfgang P. Fendler; Silke Gillessen; Raquel Perez-Lopez; Frédéric E. Lecouvet; Tara D. Barwick; Anwar R. Padhani
errShare
errSave
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
err2025-11-04
err0
PREAI
errIrbaz Bin Riaz; Syed Arsalan Ahmed Naqvi; Kunwer Sufyan Faisal; Huan He; Kaneez Zahra Rubab Khakwani; Daniel S. Childs; Jacob J. Orme; Praful Ravi; Parminder Singh; Syed A. Hussain; Kim Chi; Neeraj Agarwal; Axel S. Merseburger; Ian D. Davis; Andrew Armstrong; Maha H. Hussain; Matthew Smith; Gerhardt Attard; Bertrand Tombal; Karim Fizazi; Nick James; Aurelius Omlin; Silke Gillessen; Mohammad Hassan Murad; Eliezer M. Van Allen; Christopher J. Sweeney; Alan Haruo Bryce
errShare
errSave
A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases
err2025-11-01
err0
PREAI
errTombal, Bertrand; Saad, Fred; Gallardo, Enrique; Soares, Andrey; Loriot, Yohann; McDermott, Ray; Briers, Erik; Lagstrom, Mikael; Coens, Corneel; Poncet, Coralie; Fournier, Beatrice; Gillessen, Silke
errShare
errSave
Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutation
err2025-10-03
err0
errOAAI
errGiuseppe Salfi; Chiara Maria Agrippina Clerici; Giovanna Pecoraro; Martino Pedrani; Marialuisa Puglisi; Luigi Tortola; Ricardo Pereira Mestre; Ursula Vogl; Ilaria Colombo; Jessica Barizzi; Milo Frattini; Rossella Graffeo; Stefania Rizzo; Andrea Gallina; Fabio Monni; Nicola Fossati; Silke Gillessen; Fabio Turco
errShare
errSave
Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis
err2025-09-29
err0
errOAAI
errS.C. Yazgan; E. Yekedüz; E. Akkuş; M. Sun; S. Gillessen; K. Fizazi; R.R. McKay; C. Ay; E. Castro; N. Agarwal; T.K. Choueiri; Y. Ürün
errShare
errSave
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
err2025-09-13
err0
PREAI
errKen Herrmann; Jochen Walz; Steven MacLennan; Alberto Briganti; Philip Cornford; Johannes Czernin; Matthias Eiber; Stefano Fanti; Wolfgang P. Fendler; Karim Fizazi; Andrei Gafita; Silke Gillessen; Karolien Goffin; Boris Hadaschik; Michael S. Hofman; Thomas A. Hope; Tobias Maurer; Alicia K. Morgans; Michael J. Morris; Declan G. Murphy; Daniela E. Oprea-Lager; Piet Ost; Joe M. ÓSullivan; Olivier Rouvière; Shahneen Sandhu; Oliver Sartor; Mike Machaba Sathekge; Clare Tempany; Wim Witjes; Louise Emmett; Anders S. Bjartell
errShare
errSave